2026-01-24 - Analysis Report
**Company Overview**
Lam Research is a leading global provider of innovative wafer fabrication equipment and services to the semiconductor industry.

**Return Rate Comparison**
|  | Cumulative Return |
| --- | --- |
| Review Stock (LRCX) | 867.90% |
| Comparison Stock (VOO) | 126.41% |
| Divergence | 741.50 (simply the difference in cumulative return on the last day of the data) |
| Relative Divergence | 94.00% (the current position when the minimum-maximum fluctuation range is set to 100) |

The review stock (LRCX) has a significantly higher cumulative return rate compared to the comparison stock (VOO). This indicates a higher performance of LRCX in the given period.

**Alpha, Beta Analysis**
| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2016-2018  | 22.0% | 33.6% | 10.0% | 1.6 | 17.2B |
| 2017-2019  | 91.0% | 33.6% | 66.0% | 1.7 | 36.9B |
| 2018-2020  | 149.0% | 44.5% | 125.0% | 1.5 | 59.5B |
| 2019-2021  | 298.0% | 44.5% | 233.0% | 1.6 | 90.7B |
| 2020-2022  | 9.0% | 54.5% | 2.0% | 1.6 | 53.0B |
| 2021-2023  | 76.0% | 54.5% | 55.0% | 1.8 | 98.8B |
| 2022-2024  | -10.0% | 46.0% | -40.0% | 1.9 | 91.1B |
| 2023-2025  | 486.0% | 45.9% | 411.0% | 2.0 | 215.9B |

The review stock has shown varying levels of performance across different time periods, with some years experiencing significant growth and others experiencing losses.

**Recent Stock Price Fluctuations**
| SMA        | Value     |
|------------|-----------|
| 5-day     | $222.48   |
| 20-day    | $202.94   |
| 60-day    | $173.42   |

Recent stock price fluctuations show that the 20-day SMA is the closest to the current stock price, indicating a possible short-term trend.

**RSI, PPO Index Indicators**
| Indicator | Value      |
|-----------|------------|
| RSI       | 68.25      |
| PPO       | -0.06      |

The RSI is at 68.25, indicating that the stock is trading at the top end of the neutral zone. The PPO is -0.06, indicating a slight decline.

**Recent News & Significant Events**
The review of the provided news articles suggests that Lam Research's stock has experienced fluctuations in recent days, with some articles suggesting a potential rebound or decline in price based on upcoming earnings reports.

**Analyst Opinions**
* Key: Buy
* Mean (1=StrongBuy~5=Sell): 1.72
* Opinions: 31
* Target Price (avg/high/low): 210.32 / 265.00 / 115.00

The majority of analysts have a "Buy" recommendation for Lam Research's stock, with a target price ranging from $115 to $265.

**Recent Earnings Analysis**
| Date | EPS | Revenue |
| ---:|-----:|---------|
| 2025-10-24 | 1.24 | $5.32B |
| 2025-04-25 | 1.04 | $4.72B |
| 2025-01-31 | 0.93 | $4.38B |
| 2024-10-28 | 0.86 | $4.17B |
| 2025-10-24 | 0.86 | $4.17B |

The review of Lam Research's quarterly earnings shows a general decline in earnings per share, from 1.24 to 0.86. Revenue also shows a decline, from $5.32B to $4.17B.

**Financial Information**

**Revenue and Profitability**

| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2025-09-30 | $5.32B | 50.43% |
| 2025-06-30 | $5.17B | 50.08% |
| 2025-03-31 | $4.72B | 49.02% |
| 2024-12-31 | $4.38B | 47.37% |
| 2024-09-30 | $4.17B | 48.05% |

The review of Lam Research's quarterly financials shows a trend of declining revenue and profit margins.

**Capital and Profitability**

| Quarter | Equity | ROE |
|---------|---------|-----|
| 2025-09-30 | $10.19B | 15.39% |
| 2025-06-30 | $9.86B | 17.44% |
| 2025-03-31 | $9.51B | 13.99% |
| 2024-12-31 | $8.81B | 13.52% |
| 2024-09-30 | $8.47B | 13.18% |

The review of Lam Research's quarterly capital and profitability shows that equity has increased, and ROE (Return on Equity) has generally declined.

**Comprehensive Analysis**
Based on the review of Lam Research's return rate, Alpha, Beta analysis, recent stock price fluctuations, RSI, PPO index indicators, recent news and significant events, analyst opinions, recent earnings analysis, and financial information, we can see that the company has experienced fluctuations in recent times. The stock price has generally trended upwards but with some declines. The RSI and PPO indicators suggest a possible decline. Analysts are generally optimistic about the company, with a majority recommending a "Buy". However, there are concerns about declining revenue and profit margins.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.